IRCT20200115046147N1 IRCT 2020-02-01 Zanjan University of Medical Sciences The effect of magnesium supplements on polycystic ovarian syndrome (PCOS) The effect of magnesium supplements on clinical and metabolic variables in women with polycystic ovarian syndrome (PCOS) 2020-01-28 anticipated 40 Complete https://irct.ir/trial/45198 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Balanced Block Randomization, Blinding description: Patients are treated with prescribed medication packages by the study supervisor (supervisor). The drug packages are quite similar in form and the patient and the planner are not aware of the contents of the packages. In addition, information is collected, the patients are evaluated and the forms are completed by the planner and his assistant who are not aware of the contents of the packages; The data analysis will also be performed by the design consultant and design consultant who is unaware of the contents of the drug packages and only the patient group (group 1 or 2) is identified to analyze the data, so the study is three-blind. 3 polycystic ovarian syndrome (PCOS). Intervention 1: Intervention group: In the magnesium group, magnesium oxide supplement made by Galen's company in the form of 250 mg a day for two months will be given to patients and in the control group only placebo produced by the same company with the same form of magnesium catabolic The patient will be prescribed daily. Intervention 2: Control group: In the control group, only placebo, manufactured by Galen's company, in the same form as magnesium chelate, will be administered daily to patients for two months. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more informations